- Stocks
- Healthcare
INMD
InMode Ltd.
INMD
NASDAQ·Healthcare·Medical - Devices·Mkt cap $857.0M
$14.91
▲ +0.47%
P/E
23.90
Mkt Cap
$857.0M
52-Wk Range
$12.72–$16.74
52-Week Range
$12.72 - $16.74
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 2.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary radiofrequency technology platform providing differentiation
- Comprehensive product portfolio addressing multiple aesthetic procedures
- Strong intellectual property and patent protection
- Established global distribution network and brand recognition
Bear Case
1 risk
- Above-average volatility (beta 1.9).
Growth
Strong growth ahead
Expanding aesthetic medicine market globally with aging demographics
Value
Undervalued - trading well below Medical Devices peers
Momentum
Strong
+10.4% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying INMD right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 28, 2026
AUG 5, 2026
Reported EPS of $0.35 vs $0.35 consensus (+1.2% surprise). Revenue of $95.4M vs $94.9M expected (+0.6%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+1.2%
Revenue trend · last 8Q
—
—
-3%
+11%
-28%
+6%
+5%
-0%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$45.3M
$34.0M
$27.1M
$33.2M
$32.4M
$36.1M
$28.5M
$95.6M
Margins · last 8Q
Gross
74.8%
Operating
12.8%
Profit
17.9%
Wall Street consensus
2 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Baird · May 7, 2026
vs Industry
How INMD stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related